New antibacterials for the treatment of toxoplasmosis; a patent review

Author： Rodriguez Juan Bautista   Szajnman Sergio Hernán  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.22, Iss.3, 2012-03, pp. : 311-333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

‘Superbugs’: new antibacterials in the pipeline

By Bush K.   Macielag M.   Clancy J.  

Expert Opinion on Emerging Drugs, Vol. 5, Iss. 4, 2000-12 ,pp. : 347-365

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Ocular Infections with Topical Antibacterials

By Leeming J.P.  

Clinical Pharmacokinetics, Vol. 37, Iss. 5, 1999-11 ,pp. : 351-360

Adis International

Access to resources Recommend Favorite

Phospholipase A2 inhibitors for the treatment of inflammatory diseases: a patent review (2010 – present)

By Magrioti Victoria   Kokotos George  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 3, 2013-03 ,pp. : 333-344

Informa Healthcare

Access to resources Recommend Favorite

The emergence of factor Xa inhibitors for the treatment of cardiovascular diseases: a patent review

By Pinto Donald J P   Qiao Jennifer X   Knabb Robert M  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 6, 2012-06 ,pp. : 645-661

Informa Healthcare

Access to resources Recommend Favorite

Patents (and patent applications) on &bgr;-lactam antibacterials: January 1995 - December 1998

By Lee V.J.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 3, 1999-03 ,pp. : 269-279

Informa Healthcare

Access to resources Recommend Favorite